Sunday - December 22, 2024

Methods and Compositions for CNS Delivery of Heparan N-Sulfatase

2024-12-10

ALEXANDRIA, Virginia, Dec. 10 -- TAKEDA PHARMACEUTICAL COMPANY LIMITED, Osaka, Japan has been assigned a patent (No. US 12161702 B2, initially filed June 17, 2021) developed by ten inventors Farah Natoli, Georgetown, Massachusetts; Gaozhong Zhu, Weston, Massachusetts; Jennifer Terew, Concord, Massachusetts; Yuan Jiang, Londonderry, New Hampshire; Jamie Tsung, Wellesley, Massachusetts; Zahra Shahrokh, Weston, Massachusetts; Brian Vernaglia, Winchester, Massachusetts; Jing Pan, Boxborogh, Massachu . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Methods and Compositions for CNS Delivery of Heparan N-Sulfatase

Information Request Form

Copyright Targeted News Service 2024